AVITA Medical annual gross margin
2018
2019
2020
2021
2021
2022
2023
2024
2025
AVITA Medical Gross Margin Growth & History (RCEL)
AVITA Medical's gross margin was 82.98% for fiscal 2025.
View full AVITA Medical company overviewAVITA Medical annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 82.98% | −3.35 pp |
| 2024 | 2024-12-31 | 86.33% | +1.84 pp |
| 2023 | 2023-12-31 | 84.48% | +2.03 pp |
| 2022 | 2022-12-31 | 82.45% | −3.90 pp |
| 2021 · Dec 31 | 2021-12-31 | 86.35% | — |
| 2021 · Jun 30 | 2021-06-30 | 79.65% | +0.49 pp |
| 2020 | 2020-06-30 | 79.16% | +2.37 pp |
| 2019 | 2019-06-30 | 76.78% | +35.55 pp |
| 2018 | 2018-06-30 | 41.23% | — |
AVITA Medical quarterly gross margin
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 82.68% | +0.66 pp |
| Q1 2026 | 2026-03-31 | 82.50% | −3.07 pp |
| Q4 2025 | 2025-12-31 | 82.10% | −6.45 pp |
| Q3 2025 | 2025-09-30 | 82.12% | −2.22 pp |
| Q2 2025 | 2025-06-30 | 82.02% | −4.16 pp |
| Q1 2025 | 2025-03-31 | 85.57% | −0.80 pp |
| Q4 2024 | 2024-12-31 | 88.55% | +1.20 pp |
| Q3 2024 | 2024-09-30 | 84.34% | −0.18 pp |
| Q2 2024 | 2024-06-30 | 86.18% | +4.93 pp |
| Q1 2024 | 2024-03-31 | 86.37% | +2.18 pp |
| Q4 2023 | 2023-12-31 | 87.35% | +1.59 pp |
| Q3 2023 | 2023-09-30 | 84.51% | +1.34 pp |
| Q2 2023 | 2023-06-30 | 81.25% | −2.12 pp |
| Q1 2023 | 2023-03-31 | 84.20% | +7.78 pp |
| Q4 2022 | 2022-12-31 | 85.75% | — |
| Q3 2022 | 2022-09-30 | 83.17% | −1.33 pp |
| Q2 2022 | 2022-06-30 | 83.37% | +3.30 pp |
| Q1 2022 · Mar 31 | 2022-03-31 | 76.42% | +0.90 pp |
| Q1 2022 · Sep 30 | 2021-09-30 | 84.50% | +2.86 pp |
| Q4 2021 | 2021-06-30 | 80.08% | +2.62 pp |
| Q3 2021 | 2021-03-31 | 75.52% | −8.13 pp |
| Q2 2021 | 2020-12-31 | 83.91% | +9.87 pp |
| Q1 2021 | 2020-09-30 | 81.64% | +0.69 pp |
| Q4 2020 | 2020-06-30 | 77.46% | −1.97 pp |
| Q3 2020 | 2020-03-31 | 83.65% | +0.72 pp |
| Q2 2020 | 2019-12-31 | 74.04% | −2.69 pp |
| Q1 2020 | 2019-09-30 | 80.95% | +67.20 pp |
| Q4 2019 | 2019-06-30 | 79.43% | — |
| Q3 2019 | 2019-03-31 | 82.92% | — |
| Q2 2019 | 2018-12-31 | 76.73% | — |
| Q1 2019 | 2018-09-30 | 13.75% | — |
AVITA Medical gross margin trends
Between the periods ended 2018-06-30 and 2025-12-31, AVITA Medical's gross margin increased from 41.23% to 82.98%, a change of +41.75 percentage points. The latest reported quarter, Q2 2026, shows 82.68%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AVITA Medical source filings ↗